SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-18-042761
Filing Date
2018-02-13
Accepted
2018-02-13 16:55:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d417934dsc13ga.htm SC 13G/A 43655
  Complete submission text file 0001193125-18-042761.txt   45389
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79884 | Film No.: 18604409
SIC: 2834 Pharmaceutical Preparations